# Editas Medicine, Inc.: Form 8-K, filed Sep 2, 2025

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2025-09-02
- Accepted by EDGAR: Sep 2, 2025, 07:03 ET
- Period: 2025-09-02
- Accession: 0001650664-25-000134
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000165066425000134/edit-20250902.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000165066425000134/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000165066425000134/edit-20250902.htm

Filed Sep 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001650664-25-000134. Last ingested by Listed: Nov 9, 2026, 17:25 ET. No prices; not investment advice.